Abstracts

Li Bie, Yo‐El S. Ju, Jin Zhang, Loretta Donovan, S. Birks, Laura Grunewald, Filip Zmuda, Gwendoline Pilkington, Aseem Kaul, Y.-h. Chen, Sonika Dahiya, R. Emnett, Scott M. Gianino, David H. Gutmann, Julia Pöschl, Eugene C. Bianchi, Michael R. Bockstaller, Paul Neumann, Ulrich Schüller, A. Gevorgian, E. Morozova, И. В. Казанцев, T. Iukhta, S. Safonova, Y. Punanov, O. Zheludkova, B. Afanasyev, Martin Buss, Marc Remke, K. Gandhi, M. Kool, P. Northcott, Stefan M. Pfister, Michael D. Taylor, R. Castellino, Jeremy H. Thompson, L. Margraf, David J. Donahue, Hayden Head, Janet Murray, P. C. Burger, Matthew Wortham, Zachary J. Reitman, Yi He, Darell D. Bigner, Hong Yan, C. Lee, Jean Triscott, C. Foster, B. Manoranjan, Mary Rose Pambid, A. Fotovati, R. Berns, C. Venugopal, K. O’Halloran, A. Narendran, Satwinder Singh, A. Singhal, R. Rassekh, Carl A. Maxwell, Christopher Dunham, S. E. Dunn, Kaiji Hu, Hans Adomat, M. Moniri, M. Chin, M. Hessein, Natalia Zisman, Norbert Maurer, Emma S. Tomlinson Guns, C.a.m. Koks, Steven De Vleeschouwer, N. Graf, S. Van Gool, Esterina D’Asti, A. Huang, A. Korshunov, Janusz Rak, W. Gump, T. Moriarty, K. Skjei, S. Karkare, Pedro Castelo‐Branco, S. Choufani, Stephen C. Mack, Dympna Gallagher, Chi Zhang, D. Merino, J. Wasserman, D. T. Jones, Sidney CroulNeuro-Oncology 2013 · DOI

Abstract

INTRODUCTION: Ginsenoside Rg3 is a natural active ingredient that is extracted from Korean red ginseng root. It elevates therapeutic effect of radiotherapy and chemotherapy, but the study found that the application of Rg3 is heavily limited by its low bioavailability and poor absorption via oral administration. METHOD: Rg3-loaded PEG-PLGA-NPs (Rg3-NPs) were prepared by the modified spontaneous emulsification solvent diffusion (SESD) method, and the physicochemical characteristics of Rg3-NPs were investigated in our study. We treated primary glioblastoma with 50 mM Rg3-NPs for 48h. We then used gene expression arrays (Illumina) for genome-wide expression analysis and validated the results for genes of interest by means of Real-Time PCR. Functional annotations were then performed using the DAVID and KEGG online tools. RESULTS: MTT shows that the growth of cells can be significantly inhibited by Rg3-NPs in a dose-dependence manner. FCM test shows Rg3-NPs can be released from the conjugate nanoparticle and react with the genes in the cell nuclei causing changes in the gene molecules. We also found that cancer cells treated with Rg3-NPs undergo cell-cycle arrest at different checkpoints. This arrest was associated with a decrease in the mRNA levels of core regulatory genes as determined by microarray-analysis and verified by Real-Time PCR. Furthermore, Rg3-NPs induced the expression of apoptotic and anti-migratory proteins p53 in cell lines. CONCLUSIONS: The results of the present study, together with the results of earlier studies show that Rg3-NPs targets genes involved in the progression of the M-phase of the cell cycle. It is associated with several important pathways, which include apoptosis (p53). Rg3-NPs may be a potent cell-cycle regulation drug targeting the M-phase in glioblastoma cell lines.
BibTeX
@inproceedings{bie2013abstracts,
  author = {Li Bie and Yo‐El S. Ju and Jin Zhang and Loretta Donovan and S. Birks and Laura Grunewald and Filip Zmuda and Gwendoline Pilkington and Aseem Kaul and Y.-H. Chen and Sonika Dahiya and R. Emnett and Scott M. Gianino and David H. Gutmann and Julia Pöschl and Eugene C. Bianchi and Michael R. Bockstaller and Paul Neumann and Ulrich Schüller and A. Gevorgian and E. Morozova and И. В. Казанцев and T. Iukhta and S. Safonova and Y. Punanov and O. Zheludkova and B. Afanasyev and Martin Buss and Marc Remke and K. Gandhi and M. Kool and P. Northcott and Stefan M. Pfister and Michael D. Taylor and R. Castellino and Jeremy H. Thompson and L. Margraf and David J. Donahue and Hayden Head and Janet Murray and P. C. Burger and Matthew Wortham and Zachary J. Reitman and Yi He and Darell D. Bigner and Hong Yan and C. Lee and Jean Triscott and C. Foster and B. Manoranjan and Mary Rose Pambid and A. Fotovati and R. Berns and C. Venugopal and K. O’Halloran and A. Narendran and P. Northcott and Michael D. Taylor and Satwinder Singh and A. Singhal and R. Rassekh and Carl A. Maxwell and Christopher Dunham and S. E. Dunn and Mary Rose Pambid and R. Berns and Kaiji Hu and Hans Adomat and M. Moniri and M. Chin and M. Hessein and Natalia Zisman and Norbert Maurer and Christopher Dunham and Emma S. Tomlinson Guns and Sandra E. Dunn and C.A.M. Koks and Steven De Vleeschouwer and N. Graf and S. Van Gool and Esterina D’Asti and A. Huang and A. Korshunov and Stefan M. Pfister and Janusz Rak and W. Gump and T. Moriarty and W. Gump and K. Skjei and S. Karkare and Pedro Castelo‐Branco and S. Choufani and Stephen C. Mack and Dympna Gallagher and Chi Zhang and D. Merino and J. Wasserman and M. Kool and D. T. Jones and Sidney Croul},
  title = {{Abstracts}},
  booktitle = {Neuro-Oncology},
  year = {2013},
  doi = {10.1093/neuonc/not047},
}

Loading related content...

Figure